These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33995812)

  • 1. Risks of cardio-vascular diseases among highly active antiretroviral therapy (HAART) treated HIV seropositive volunteers at a treatment centre in Lagos, Nigeria.
    Ekun OA; Fasela EO; Oladele DA; Liboro GO; Raheem TY
    Pan Afr Med J; 2021; 38():206. PubMed ID: 33995812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
    Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
    PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria.
    Sulaiman MM; Shettima J; Ummate I; Arogundade FA; Yusuph H; Nwankwo E; Sanusi AA; Akinsola A
    Saudi J Kidney Dis Transpl; 2022; 33(1):72-79. PubMed ID: 36647981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haptoglobin phenotypes with weak antioxidant capacity increase risk factors of cardiovascular disease in Ghanaian HIV-infected patients on highly active antiretroviral therapy.
    Tagoe EA; Tagoe INA; Kuleape JA; Puplampu P; Amanquah S; Asare-Anane H; Quaye O
    Trop Med Int Health; 2019 Jun; 24(6):766-774. PubMed ID: 30851231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orofacial lesions associated with long-term highly active antiretroviral therapy among HIV-seropositive adults in Ibadan, Nigeria.
    Abe OE; Fagbule OF; Olaniyi OO; Adisa AO; Gbolahan OO
    Pan Afr Med J; 2021; 38():370. PubMed ID: 34367449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study.
    Abebe M; Kinde S; Belay G; Gebreegziabxier A; Challa F; Gebeyehu T; Nigussie P; Tegbaru B
    BMC Res Notes; 2014 Jun; 7():380. PubMed ID: 24950924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
    Muhammad S; Sani MU; Okeahialam BN
    Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between highly active antiretroviral therapy (HAART) and hypertension in persons living with HIV/AIDS at the Bamenda regional hospital, Cameroon.
    Pangmekeh PJ; Awolu MM; Gustave S; Gladys T; Cumber SN
    Pan Afr Med J; 2019; 33():87. PubMed ID: 31489065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.
    Verweel G; van Rossum AM; Hartwig NG; Wolfs TF; Scherpbier HJ; de Groot R
    Pediatrics; 2002 Feb; 109(2):E25. PubMed ID: 11826235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).
    Dong KL; Bausserman LL; Flynn MM; Dickinson BP; Flanigan TP; Mileno MD; Tashima KT; Carpenter CC
    J Acquir Immune Defic Syndr; 1999 Jun; 21(2):107-13. PubMed ID: 10360801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
    Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
    Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid profile in HIV/AIDS patients in Nigeria.
    Adewole OO; Eze S; Betiku Y; Anteyi E; Wada I; Ajuwon Z; Erhabor G
    Afr Health Sci; 2010 Jun; 10(2):144-9. PubMed ID: 21326966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyslipidaemia and dysglycaemia in HIV-infected patients on highly active anti-retroviral therapy in Kumasi Metropolis.
    Ngala RA; Fianko K
    Afr Health Sci; 2013 Dec; 13(4):1107-16. PubMed ID: 24940339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
    Achila OO; Abrhaley F; Kesete Y; Tesfaldet F; Alazar F; Fisshaye L; Gebremeskel L; Mehari R; Andemichael D
    PLoS One; 2022; 17(7):e0270838. PubMed ID: 35776747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria.
    Onyedum CC; Young EE; Iroezindu MO; Chukwuka CJ; Nwagha UI
    Indian J Endocrinol Metab; 2014 Sep; 18(5):631-6. PubMed ID: 25285278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
    Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
    BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
    Koppel K; Bratt G; Eriksson M; Sandström E
    Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.